Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 48Lung Neoplasms 24Carcinoma, Hepatocellular 24Small Cell Lung Carcinoma 16Urinary Bladder Neoplasms 12Cholangiocarcinoma 12Breast Neoplasms 10Biliary Tract Neoplasms 10Neoplasms 9Neoplasm Metastasis 9Liver Neoplasms 9Pancreatic Neoplasms 7Carcinoma 6Endometrial Neoplasms 5Colorectal Neoplasms 5Triple Negative Breast Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Neoplasms by Site 4Gallbladder Neoplasms 4Carcinoma, Transitional Cell 4Stomach Neoplasms 3Respiratory Tract Neoplasms 3Ovarian Neoplasms 3Carcinoma, Renal Cell 3Bile Duct Neoplasms 3Adenocarcinoma 3Thyroid Neoplasms 2Thoracic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2

Interventions

tremelimumab 2pembrolizumab 2Nivolumab 2Carboplatin 2poly ICLC 1osimertinib 1lenvatinib 1durvalumab 1cemiplimab 1balstilimab 1Vascular Endothelial Growth Factor A 1Peptides 1Pemetrexed 1Paclitaxel 1Ipilimumab 1Docetaxel 1Blood Specimen Collection 1Antibodies, Bispecific 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Mellitus, Insulin-Dependent, 12 × durvalumab × 90 days × Clear all
NCT06564623 2026-05-08

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Recruiting
25 enrolled
Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Biliary Tract Neoplasms, Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡